研究業績

英文総説

(*corresponding author)(§=equally contribution)

2024

  1. Takakura Y, Hanayama R, Akiyoshi K, Futaki S, Hida K, Ichiki T, IshiiWatabe A,Kuroda M, Maki K, Miura Y, Okada Y, Seo N, Takeuchi T, Yamaguchi T, Yoshioka Y: Quality and Safety Considerations for Therapeutic Products Based on ExtracellularVesicles, Pharmaceutical Research, 2024, doi.org/10.1007/s11095-024-03757-4

2023

  1. Morimoto M, Maishi N, Hida K: Acquisition of drug resistance in endothelial cells by tumor-derived extracellular vesicles and cancer progression, Cancer Drug Resistance, 2023,  doi: 10.20517/cdr.2023.121.
  2. Yu Li, Maishi N, Matsuda A, Hida K*: The functional network of biglycan: a new frontier in tumor progression, Proteoglycan Res, 2023(IF=0) doi: 10.1002/pgr2.11
  3. Haruhisa Watanabe , Nako Maishi, Marie Hoshi-Numahata, Mai Nishiura, Atsuko Nakanishi-Kimura, Kyoko Hida and Tadahiro Iimura*: Skeletal-Vascular Interactions in Bone Development, Homeostasis, and Pathological Destruction, Int. J. Mol. Sci. 2023, 24, 10192(IF= 6.132) doi:10.3390/ijms241310912
  4. Hida K, Maishi N, Matsuda A, Yu L: Beyond starving cancer, antiangiogenic therapy, J Med Ultrasonic, 2023(IF= 1.457 )  doi:10.1007/s10396-023-01310-1

2022

  1. Hida K, Maishi N, Matsuda A, Yu L: Beyond starving cancer, antiangiogenic therapy, J Med Ultrasonic, in press
  2. Lucas Treps, Ann Ager and Kyoko Hida K: Editorial:Tumor Vessels as Directors of the Tumor Microenvironment: New Findings, Current Challenges & Perspectives, Front. Cell Dev. Biol. Volume 10, Article 885670, March 2022
  3. Hida K, Maishi N, Takeda R, Hida Y: Metastasis, “The Roles of Tumor Endothelial Cells in Cancer Metastasis”, Exon Publications, Mar 13, 2022

2021

  1. George N.Tzanakakis, Eirini-Maria Giatagana, Aikaterini Berdiaki, Ioanna Spyridaki, Hida K, Monica Neagu, Aristidis M. Tsatsakis, and Dragana Nikitovic *: The role of IGF/IGF-IR-signaling and extracellular matrix effectors in sarcoma pathogenesis, Cancers, 13(10), 2478, 2021

2020

  1. Annan DA, Kikuchi H, Maishi N, Hida Y and Hida K*: Tumor Endothelial Cell—A Biological Tool for Translational Cancer Research, Int. J. Mol. Sci., 21, 3238, 2020

2019

  1. Maishi N, Annan DA, Kikuchi H, Hida Y and Hida K*: Tumor endothelial heterogeneity in cancer progression, Cancers, 2019, 11(10), 1511

2018

  1. *Hida K., Maishi N., Dorcas A. Annan, Hida Y.:Contribution of Tumor Endothelial Cells in Cancer Progression, Int J Mol Sci, in press
  2. *Hida K., Maishi N.:Abnormalities of tumor endothelial cells and cancer progression, Oral Sci Int, 15(1), 1-6, 2018

2017

  1. *Hida K., Maishi N.:Abnormalities of tumor endothelial cells and cancer progression, Oral Sci Int, 15(1), 1-6, 2017
  2. Maishi N., Hida K.:Tumor endothelial cells accelerate tumor metastasis, Cancer Sci, 108(10), 1921-1926, 2017
  3. *Hida K., Kikuchi H., Maishi N., Hida Y:ATP-binding cassette transporters in tumor endothelial cells and resistance to metronomic chemotherapy, Cancer Lett, 400, 305-310, 2017

2016

  1. *Hida K., Maishi N., Torii C., Hida Y.:Tumor Angiogenesis—Characteristics of Tumor Endothelial Cells, Int J Clin Oncol, 21(2),206-212,2016
  2. *Hida K., Maishi N., Sakurai Y., Hida Y., Harashima H.:Heterogeneity of tumor endothelial cells and drug delivery, Adv Drug Deliv Rev99(Pt B), 140-147, 2016

2013

  1. *Hida K., Ohga N., Akiyama K., Maishi N., Hida Y.:Heterogeneity of tumor endothelial cells, Cancer Sci, 104(11), 1391-1395, 2013
  2. *Hida K., Akiyama K., Ohga N., Maishi N., Hida Y.: Tumor endothelial cells acquire drug resistance in a tumor microenvironment, J Biochem,153(3), 243-249, 2013

2011

  1. *Hida K., Kawamoto T., Ohga N., Akiyama K., Hida Y., Shindoh M.: Altered angiogenesis in the tumor microenvironment, Pathol Int, 61(11), 630-637, 2011

2010

  1. Higashino F., *Hida K., Kitamura T., Ohga N., Shindoh M.:Aberrant control of transcription and transportation of oncogenic mRNA in carcinogenesis,Oral Sci Int, 7(1), 11-18, 2010
  2. *Hida K., Ohga N., Kurosu T.,Totsuka Y.andShindoh M.: Crosstalk between blood vessels and tumor microenvironment,Oral Sci Int, 7(1), 1-10, 2010

2009

  1. *Hida K., Ohga N.,Hida Y. and Shindoh M.: Significance of Antiangiogenic Therapy in Head and Neck Cancer-Heterogeneity of Tumor Endothelium. Jpn Dent Sci Review, 46, 26-32, 2009

2008年以前

  1. *Hida K., Hida Y. an Shindoh M.: Understanding Abnormality of Tumor Endothelial Cells to Develop Ideal Anti-angiogenic Therapies. Cancer Sci. 99 (3), 459-466, 2008
  2. *Hida K.. and Klgsbrun M.: A new perspective on tumor endothelial cells; Unexpected Chromosome and centrosome abnormalities. Cancer Res, 65 (7), 1-4, 2005